Leading India-Based CRO, Signs Pristima® and Savante™ Software Licensing Agreement with Xybion Corporation
LAWRENCEVILLE, N.J. (PRWEB) MARCH 12, 2018 Xybion Corporation, a US-based global technology solutions provider for companies operating in the highly regulated industries, announced today that Jai Research Foundation, a leading India-based CRO with global operations in the U.K, U.S and Japan, has signed a software licensing agreement for Pristima®, Xybion’s flagship preclinical solution, and Savante™, its popular module for production of FDA compliant SEND submissions.
This agreement is the conclusion of an exhaustive search by JRF Global to find a best-of-breed preclinical solution that would best serve its business needs and requirements. As a result, JRF Global will leverage Pristima’s core components, such as Clinical Pathology, Animal Room, Necropsy Room, and Histopathology to support its pre-clinical laboratory services.
Xybion will provide Pristima® and Savante™ Software to support JRF Global’s AAALAC and OECD GLP accredited research facility. In addition, Pristima® will be interfaced to support real-time communications with clinical pathology instruments at JRF Global through interfaces and file import for legacy instruments.
“JRF Global was looking for a comprehensive software solution, which would align with our core values of reliability, innovation and integrity and enhance our staff productivity while optimizing our pre-clinical operations,” stated by Dr. Abhay Deshpande, CEO of JRF Global. “We went through a thorough analysis of requirements mapping and we found that Xybion’s partnership and their industry leading Pristima software platform is the right solution fit for our organization.”
Carlos Frade, Vice President of Preclinical R&D Solutions at Xybion expressed confidence in this partnership stating, “We are excited about being selected by JRF Global for our pre-clinical solution suite. With Xybion’s decades of expertise in the pre-clinical market and deployment of our Pristima® and Savante™ solutions, I am certain that JRF Global will accrue immense benefits, supporting their mission of Quality Science & Integrity in Research.”
Xybion’s Chief Executive Officer, Dr. Pradip Banerjee went on to say “We look forward to a long-term relationship with JRF Global, to support their global reach of preclinical research services. At Xybion, we strive to earn the trust and support of our clients and create a lasting position of a valued partner.” Dr. Banerjee continued, “This partnership is another indication that Xybion’s reputation continues to grow globally as we seek to set an industry benchmark for preclinical solutions in the APAC market.”
About Xybion Corporation
Xybion is the leading provider of software, services and consulting for global corporations operating in highly regulated industries. Our unique solutions focus on regulatory compliance, GRC, quality management, GLP, integrated preclinical lab management, early-stage drug discovery, content migration and systems validation. Xybion specializes in helping companies improve their overall compliance processes and provides a complete view into organizational risk across global organizational models.
Xybion’s combination of software, business process management, services, validation, and staffing enables us to cover a broad spectrum of critical business needs for companies and we deliver our solutions on a global scale. Since its founding in 1977, Xybion Corporation has supported, through software, services and consulting, 100% of the top 20 global life sciences companies. Our leadership in this dynamic and ever-changing industry has been a cornerstone of our high-value reputation.
About Jai Research Foundation
Established as a Research Laboratory in 1977, Jai Research Foundation is the leading pre-clinical Contract Research Organization in Asia, with its facilities at Valvada, near Vapi, Gujarat, India. JRF Global’s research facility is accredited by AAALAC as well as Committee for the Purpose of Control and Supervision of Experiments on Animals (35/1999/CPCSEA) with respect to humane and ethical treatment of laboratory animals. JRF Global was endorsed for compliance with OECD principles of GLP in 1996 by GLP Monitoring authority of the Government of the Netherlands. JRF Global is now certified by NGCMA (GLC/C-0031), post India’s entry into the OECD MAD (Mutual Acceptance of Data) council, as a full adherent since 2011.
The facility comprises of over 158,000 Sq. Ft. of floor space accommodating dedicated laboratories for Toxicology from India, and another 50,000 Sq.Ft. for Product chemistry, Analytical, Bioanalytical and Residue Chemistry, Ecotoxicology, Environmental fate and metabolism studies, offered from India, the US and Japan. Their expertise spans across in vitro as well as in vivo safety studies with specialisation in inhalation and reproductive toxicity, as well as challenging analytical solutions. JRF Global believes remaining in the forefront of meeting the new regulatory studies in Asia. They were the first CRO in Asia to launch and the complete bouquet of in vitro eye, skin as well as kinetic studies for dermal absorption and penetration, as well as Tier I Endocrine Disruption suite.